Evidence map›Paper›PMID 41466129›Full record

ArticleNPJ digital medicine2025

Interpretable multimodal deep learning improves postoperative risk stratification in intrahepatic cholangiocarcinoma in multicentre cohorts.

Mingyu Wan, Yongfeng Ding, Yanli Wang, Yunlu Jia, Siqi Wu, Wenxin Qu, Yifan Xu, Wenguang Fu, Michael P Timko, Ledong Wan and 11 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Mingyu Wan *Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, Hangzhou, China.
Yongfeng Ding *Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, Hangzhou, China.
Yanli Wang *Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yunlu JiaDepartment of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, Hangzhou, China.
Siqi WuThe First Clinical School of Medicine, Zhengzhou University, Zhengzhou, China.
Wenxin QuDepartment of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yifan XuDepartment of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Wenguang FuDepartment of Hepatobiliary Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Michael P TimkoDepartments of Biology and Public Health Sciences, University of Virginia, Charlottesville, VA, USA.
Ledong WanDepartment of Pharmacological Sciences, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, USA.
Le YingDepartment of Medicine, Monash University, Clayton, VIC, Australia.
Chanqi YeDepartment of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, Hangzhou, China.
Ruyin ChenDepartment of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, Hangzhou, China.
Qiong LiDepartment of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, Hangzhou, China.
Yuqing HeDepartment of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, Hangzhou, China.
Keyi XuDepartment of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, Hangzhou, China.
Nong XuDepartment of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, Hangzhou, China.
Jinzhang ChenDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China. chenjinzhang@smu.edu.cn.
Dayong ZhengDepartment of Oncology, Shunde Hospital, Southern Medical University, Shunde, China. zhengdayong@hotmail.com.
Yifei ShenDepartment of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. yifeishen@zju.edu.cn.
Jian RuanDepartment of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, Hangzhou, China. software233@zju.edu.cn.

Funding

A Project Supported by Scientific Research Fund of Zhejiang Provincial Education Department Y202045631Beijing Xisike Clinical Oncology Research Foundation Y-MSDZD2022-0161National Natural Science Foundation of China 82402729National Natural Science Foundation of China 82473004"Pioneer" and "Leading Goose" R&D Program of Zhejiang 2024C03175Zhejiang Provincial Natural Science Foundation of China LQ23H200003Zhejiang Provincial Natural Science Foundation of China LY22H160019
6 · The paper itself

Abstract

Surgical resection is the primary curative treatment for intrahepatic cholangiocarcinoma (ICC), yet high postoperative recurrence rates pose a significant challenge. We developed an interpretable, transformer-based deep-learning pipeline that integrates multimodal data-including clinical variables, radiomic features, and whole-slide pathology images-by fusing a pre-trained encoder with a transformer network. To biologically validate our model, we leveraged spatial transcriptomics and proteomics to decipher the attention mechanisms underlying its predictions. It demonstrated robust performance in predicting 2-year overall survival, with area under the curve (AUC) values of 0.952 (95% CI: 0.909-0.983), 0.924 (95% CI: 0.804-1.000), and 0.924 (95% CI: 0.828-0.993) in three independent validation cohorts. Interrogation via spatial multi-omics revealed that the model's attention was preferentially focused on regions histologically and molecularly associated with tumor invasion and aggressive behavior. We present a novel, interpretable multimodal deep-learning framework that achieves superior postoperative risk stratification for ICC patients.

Identifiers

PMID41466129
PMCPMC12855921

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.